United States · 
Who invested in VitaPath Genetics?
VitaPath Genetics's investors include Mohr Davidow Ventures and XSeed Capital.
201020112012
$6.0MSeries A$4.2MSeries B$4.7MSeries C$328KGrowth$5.0MSeries C
United States · Series C startup
Who invested in VitaPath Genetics
5 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow VitaPath Genetics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$20Mraised across 5 rounds since 2009, from 5 sources
$6.0MSeries A$4.2MSeries B$4.7MSeries C$328KGrowth$5.0MSeries C
- Latest round
- Series C, $5.0MAug 2012
- Biggest round
- $6.0MSeries A · Nov 2009
- Step-upi
- 15.4×
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $6.0M Nov 2009
- Biggest round
- $6.0M Series A · Nov 2009
- Usual gap between rounds
- 8 months the median of 4
The rounds
- Aug 2012Series C$5.0M
No investor was named in the report.
Reported by sec.govSEC filing: $5.0M sold, first sale Apr 2012
- Jul 2012Growth$328K2 returning
From a historical funding recordSEC filing: $5.0M sold, first sale Apr 2012
- Apr 2012Series C$4.7M2 returning
From a historical funding recordSEC filing: $4.7M sold, first sale Apr 2012
- Aug 2011Series B$4.2M
No investor was named in the report.
Reported by sec.govSEC filing: $4.2M sold, first sale Jul 2011
- Nov 2009
Founders and team
From the SEC filings it signed: 4 on the team.
- Dennis GilbertExecutive Officer, Directori
- Girish PutchaExecutive Officeri
- Jasper RineExecutive Officer, Directori
- Richard TaylorExecutive Officeri
On the board, as filediCatherine M. BurzikMichael BorrusRowan Chapman
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about VitaPath Genetics
How much has VitaPath Genetics raised?
VitaPath Genetics has raised $20M across 5 rounds since 2009.
When did VitaPath Genetics last raise?
VitaPath Genetics's most recent round was a Series C of $5.0M in Aug 2012.
What was VitaPath Genetics's biggest round?
VitaPath Genetics's largest round on record is $6.0M (Series A), in Nov 2009.
Who backed VitaPath Genetics first?
VitaPath Genetics's first round on record, in Nov 2009, was backed by Mohr Davidow Ventures and XSeed Capital.
What stage is VitaPath Genetics at?
VitaPath Genetics's latest named round is a Series C, in Aug 2012.
Where is VitaPath Genetics based?
VitaPath Genetics is based in the United States.
Companies like VitaPath Genetics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.